ADCT — ADC Therapeutics SA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Annual balance sheet for ADC Therapeutics SA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	20-F	10-K	10-K	10-K	10-K
Standards:	IFRS	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	467	326	279	251	261
Net Total Accounts Receivable
Net Total Receivables	30.6	73	25.2	20.3	29.1
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	525	435	336	307	306
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	11.2	10.3	16.1	13.4	1.3
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	618	491	355	322	323
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	73.9	81.9	67.7	80.5	70.2
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	452	411	503	525	509
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	166	79.5	-148	-203	-186
Total Liabilities & Shareholders' Equity	618	491	355	322	323
Total Common Shares Outstanding